Vivos Therapeutics (VVOS) Competitors $3.47 -0.17 (-4.67%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$3.52 +0.05 (+1.41%) As of 09/12/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VVOS vs. RCEL, OBIO, EDAP, NSPR, ZJYL, HYPR, FONR, BDMD, APYX, and VANIShould you be buying Vivos Therapeutics stock or one of its competitors? The main competitors of Vivos Therapeutics include Avita Medical (RCEL), Orchestra BioMed (OBIO), Edap Tms (EDAP), InspireMD (NSPR), Jin Medical International (ZJYL), Hyperfine (HYPR), Fonar (FONR), Baird Medical Investment (BDMD), Apyx Medical (APYX), and Vivani Medical (VANI). These companies are all part of the "medical equipment" industry. Vivos Therapeutics vs. Its Competitors Avita Medical Orchestra BioMed Edap Tms InspireMD Jin Medical International Hyperfine Fonar Baird Medical Investment Apyx Medical Vivani Medical Vivos Therapeutics (NASDAQ:VVOS) and Avita Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, dividends, institutional ownership, profitability and valuation. Which has more volatility and risk, VVOS or RCEL? Vivos Therapeutics has a beta of 7.02, suggesting that its stock price is 602% more volatile than the S&P 500. Comparatively, Avita Medical has a beta of 1.58, suggesting that its stock price is 58% more volatile than the S&P 500. Is VVOS or RCEL more profitable? Avita Medical has a net margin of -68.87% compared to Vivos Therapeutics' net margin of -99.49%. Vivos Therapeutics' return on equity of -232.76% beat Avita Medical's return on equity.Company Net Margins Return on Equity Return on Assets Vivos Therapeutics-99.49% -232.76% -84.30% Avita Medical -68.87%-632.62%-71.52% Which has higher valuation & earnings, VVOS or RCEL? Vivos Therapeutics has higher earnings, but lower revenue than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than Vivos Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVivos Therapeutics$14.39M1.81-$11.14M-$1.68-2.07Avita Medical$74.88M1.62-$61.85M-$1.97-2.31 Do analysts recommend VVOS or RCEL? Vivos Therapeutics currently has a consensus target price of $4.92, indicating a potential upside of 41.69%. Avita Medical has a consensus target price of $11.60, indicating a potential upside of 154.39%. Given Avita Medical's higher probable upside, analysts clearly believe Avita Medical is more favorable than Vivos Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vivos Therapeutics 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Avita Medical 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Do insiders & institutionals believe in VVOS or RCEL? 26.4% of Vivos Therapeutics shares are owned by institutional investors. Comparatively, 27.7% of Avita Medical shares are owned by institutional investors. 3.0% of Vivos Therapeutics shares are owned by insiders. Comparatively, 2.8% of Avita Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media prefer VVOS or RCEL? In the previous week, Avita Medical had 4 more articles in the media than Vivos Therapeutics. MarketBeat recorded 8 mentions for Avita Medical and 4 mentions for Vivos Therapeutics. Vivos Therapeutics' average media sentiment score of 1.26 beat Avita Medical's score of 0.63 indicating that Vivos Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vivos Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Avita Medical 1 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryVivos Therapeutics beats Avita Medical on 9 of the 16 factors compared between the two stocks. Get Vivos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VVOS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VVOS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VVOS vs. The Competition Export to ExcelMetricVivos TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$27.32M$2.60B$5.85B$10.14BDividend YieldN/A56.52%5.68%4.60%P/E Ratio-2.0723.8575.3425.98Price / Sales1.81529.66514.97181.19Price / CashN/A171.1637.5660.44Price / Book2.575.3712.156.29Net Income-$11.14M$32.95M$3.29B$271.07M7 Day Performance-15.78%1.28%0.75%3.87%1 Month Performance-24.73%6.09%4.82%4.88%1 Year Performance17.63%-2.15%60.59%26.12% Vivos Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VVOSVivos Therapeutics2.8291 of 5 stars$3.47-4.7%$4.92+41.7%+21.3%$27.32M$14.39M-2.07160Positive NewsAnalyst ForecastShort Interest ↓RCELAvita Medical2.485 of 5 stars$4.19-0.5%$11.60+176.8%-53.0%$111.54M$64.25M-2.13130OBIOOrchestra BioMed3.1007 of 5 stars$2.71-0.7%$13.50+398.2%-55.5%$104.71M$2.64M-1.484Short Interest ↑EDAPEdap Tms2.235 of 5 stars$2.80+2.2%$8.50+203.6%-23.7%$104.70M$63.02M-4.59230Short Interest ↑NSPRInspireMD3.626 of 5 stars$2.46+2.5%$4.50+82.9%-11.9%$102.63M$7.07M-3.2850News CoveragePositive NewsShort Interest ↓ZJYLJin Medical InternationalN/A$0.65+3.6%N/A-75.1%$102.26M$23.50M0.00245Short Interest ↑HYPRHyperfine1.3565 of 5 stars$1.27+6.7%$1.28+1.0%+42.0%$99.80M$12.89M-2.44190FONRFonar1.1471 of 5 stars$15.58-0.1%N/A-5.2%$96.64M$103.02M12.46480News CoverageBDMDBaird Medical InvestmentN/A$2.44-1.2%N/AN/A$87.18MN/A0.00N/APositive NewsAPYXApyx Medical2.4909 of 5 stars$2.06flatN/A+69.4%$77.91M$48.10M-4.58270Short Interest ↓VANIVivani Medical2.717 of 5 stars$1.28flat$4.00+212.5%-2.4%$75.83MN/A-2.8420 Related Companies and Tools Related Companies Avita Medical Competitors Orchestra BioMed Competitors Edap Tms Competitors InspireMD Competitors Jin Medical International Competitors Hyperfine Competitors Fonar Competitors Baird Medical Investment Competitors Apyx Medical Competitors Vivani Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VVOS) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VVOS Stock Alerts